-
Semaglutide: Play an important role in Global Weight Loss Market
Sep , 04 2024
Semaglutide, a GLP-1 receptor agonist, is revolutionizing the management of type 2 diabetes and weight loss. It's available in injectable and oral forms, marketed as Ozempic, Rybelsus for diabetes, an...
read more
-
The Rise of Alpha-Ketoglutarate (AKG) in the Anti-Aging Landscape
Aug , 07 2024
The Rise of Alpha-Ketoglutarate (AKG) in the Anti-Aging Landscape realm of scientific discoveries that hold the promise of extending human lifespan and enhancing overall health, the role of mitochondr...
read more
-
Synthetic Biology Revolutionizing Vitamin Production: Towards Sustainable Development
Aug , 06 2024
Synthetic biology is increasingly becoming a green and efficient alternative in the production of vitamins. Microbial fermentation synthesis, as a key technological approach, avoids the use of toxic c...
read more
-
Water-Soluble Coenzyme Q10: Chinese Innovations in Advancing Formulations
Aug , 05 2024
Coenzyme Q10 (CoQ10) is a natural lipid compound found widely in the human body, known for its role in enhancing energy metabolism in myocardial cells. Beyond this, it boasts significant antioxidant, ...
read more
-
Biological Enzyme Breakthrough: Revolutionizing Hormonal Drug Production
Aug , 05 2024
Recently, the Tianjin Institute of Industrial Biotechnology of the Chinese Academy of Sciences achieved a significant breakthrough in biological enzyme catalysis technology for treating hormonal drugs...
read more
-
Semaglutide in China: Advancements in Production, Quality, and Competitive Pricing
Jul , 25 2024
Semaglutide (CAS No: 910463-68-2) belongs to the class of GLP-1 receptor agonists and is used both as an antidiabetic for treating type 2 diabetes and as an anti-obesity medication for long-term weigh...
read more
-
EU's Approval of Novel HMOs Ingredients Including 2'-FL, 3-FL, and 6'-SL for Food Applications
Jul , 09 2024
In recent years, the European Union (EU) has paid particular attention to the category of Novel Foods during its approval process, with a focus on Human Milk Oligosaccharides (HMOs). HMOs, as crucial ...
read more
-
Two types of Linkers Utilized in Antibody Drug Conjugates (ADCs): cleavable linkers and non-cleavable linkers.
Jun , 25 2024
In antibody drug conjugates (ADCs), two types of linkers are typically used: cleavable linkers and non-cleavable linkers. Cleavable linkers release the cytotoxic payload near the desired location with...
read more
-
The key factors driving the ADC linker and antibody conjugation technologies market
Jun , 25 2024
The key factors driving the ADC linker and antibody conjugation technologies market can be summarized as follows: Growing Prevalence of Oncological Disorders: Cancer and other oncological disorders ha...
read more
IPv6 network supported
English
中文
français
Deutsch
русский
español
português
العربية
日本語
한국의
Türkçe
